ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1924

Cleveland Clinic Dual Energy X-Ray Absorptiometry Registry, A Web-Based Tool Designed For Efficient Collection Of Bone Density and Osteoporosis Related Clinical Risk Factor Data

Chad L. Deal1, Gregory J. Strnad2, Robert A. Overman3,4 and Boris Bershadsky2,5, 1Dept of Rheum & Imm Dis /A 50, Cleveland Clinic, Cleveland, OH, 2Orthopaedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH, 3Eshelman School of Pharmacy - Division of Pharmaceutical Policy and Outcomes, University of North Carolina, Chapel Hill, NC, 4Rheumatology, Cleveland Clinic, Cleveland, OH, 5School of Public Health, University of Minnesota, Minneapolis, MN

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: osteoporosis, Quality Indicators, quality of care, registries and treatment

  • Tweet
  • Email
  • Print
Session Information

Title: Health Services Research, Quality Measures and Quality of Care - Innovations in Health Care Delivery

Session Type: Abstract Submissions (ACR)

Background/Purpose:

A patient registry is an organized system that collects uniform data to allow evaluation of specific outcomes for a population with a particular disease. They can enable observation of the natural history of disease, clinical/cost effectiveness, treatment, quality of care, and factors that influence prognosis and outcomes. Osteoporosis research using administrative claims lacks clinical characteristics including bone mineral density (BMD) and fracture risk. To fill this gap a dual energy x-ray absorptiometry (DXA) registry was established at the Cleveland Clinic (CCF) in 2009.

Methods: The CCF DXA Data Entry System is a web-based intranet tool designed to capture data important to patient care and osteoporosis research.  The system receives real-time scheduling messages from the electronic medical record, generates an online data collection form for each DXA bone density scan appointment, and pre-loads them with patients’ demographic information.. DXA technologists log in from any workstation connected to the intranet and are guided through a data entry page for each appointment that helps to ensure complete and accurate data collection. Data on bone density (T and Z-scores, g/cm2), self-reported osteoporosis treatment, and FRAX® clinical risk factors are recorded. From 2009 through 2012, data on a total of 35,373 patients were entered into the registry, which represents 83.6% of the eligible population (4.3% missing data, 12.1% refused) and are stored in a secure SQL Server database and have been successfully linked with 99.1% of patients’ medical record data using Explorys Inc. proprietary software. In 2013, FRAX®10-year risk of major osteoporotic fracture and hip fracture was computed for all registry subjects.

Results: The registry includes 28,095 postmenopausal women, 5,079 men ≥50, 1,549 premenopausal women, and 650 men <50. Of these, 11.9% of postmenopausal women, 9.6% of men ≥50, 4.8% of premenopausal women, and 6.5% of men <50 have now had a 2nd DXA. To date we have investigated the relationship between registry data (FRAX®clinical risk factors and bone mineral density) and initiation of drug therapies per NOF guidelines, evaluated the frequency of DXA in organ transplant patients, and the rate of osteoporosis therapy in glucocorticoid treated subjects, among other projects. We found that 62.4% of rheumatologists and 52.2% of non-rheumatologists had started osteoporosis therapy within 365 days after their patient had a T-score ≤ 2.5, that 78% of patients on glucocorticoids had osteoporosis therapy initiated within 6-months, and that 42.5% of patients with a T-score <-2.5 had a follow-up DXA within 3-years. Ongoing projects includes evaluation of premenopausal women (n= 176) and men <50 (n= 161) with Z-score ≤ 2.0 (low bone mass for age), glucocorticoid users, effect of BMI and vitamin D on BMD, changes in BMD over time, and possible interventions for patients with a T-score ≤-2.5 who do not report osteoporosis therapy.

Conclusion: The CCF DXA Registry has enrolled 35, 373 patients with approximately 10-15,000 new patients each year. This large and longitudinal registry offers opportunities to monitor quality indicators, assess patient care, and conduct observational and interventional research.


Disclosure:

C. L. Deal,
None;

G. J. Strnad,
None;

R. A. Overman,
None;

B. Bershadsky,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cleveland-clinic-dual-energy-x-ray-absorptiometry-registry-a-web-based-tool-designed-for-efficient-collection-of-bone-density-and-osteoporosis-related-clinical-risk-factor-data/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology